glp-1 news today 2025 obesity drug A nice article in The Hindu today highlights the glp-1 obesity drug news today

Study Selection We selected pharmacokinetic studies of any injectable GLP1RA given with an oral medication, and product prescribing sheets reporting data without access to the original study

Originally developed and positioned as treatments for type 2 diabetes, these agents are now equally associated with weight management, reshaping how clinicians, patients, and pharmacies understand metabolic disease

Reduce belly fat, boost metabolism & confidence

*Based on preclinical studies, can support your bodys natural GLP-1 production

Ro is is working with Novo Nordisk on the nationwide launch of the new Wegovy pill

Retatrutide emerges as a promising multi-pathway therapeutic, attracting significant clinical interest for its potent effects on weight loss and metabolic control